Insider · CIK 0001967221
Michael Klichinsky
Files at CARM (Carisma Therapeutics Inc.). First filing Oct 3, 2025, latest Oct 8, 2025.
Michael Klichinsky files SEC Form 4 as officer at CARM (Carisma Therapeutics Inc.). Since Oct 3, 2025, Michael Klichinsky has reported 0 open-market buys worth $0 and 2 open-market sells worth $139k, the latest filed on Oct 8, 2025.
A track record needs three past buys with six months of prices behind them; Michael Klichinsky has 0, so none is measured yet.
The newest scored trade: sold $14k of CARM on Oct 7, 2025, filed Oct 8, 2025, scored 20 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CARM: Carisma Therapeutics Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | CARMsell Carisma Therapeutics Inc. | $14k 56,982 shares | -100% | - | |
| 45Moderate | CARMsell Carisma Therapeutics Inc. | $124k 484,347 shares | -100% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 6, 2025 | CARM Carisma Therapeutics Inc. | 56,982 0.14% of outstanding | $14k | Oct 7, 2025 | $124k |
| Sep 30, 2025 | CARM Carisma Therapeutics Inc. | 484,347 1.16% of outstanding | $134k | Sep 30, 2025 | none |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 7, 2025 | CARM Carisma Therapeutics Inc. | MOption exercise Common Stock | +56,982 | $0.11 | $6,268 | 56,982 | Oct 8, 2025 |
| Oct 7, 2025 | CARM Carisma Therapeutics Inc. | SOpen-market sale Common Stock | -56,982 | $0.25 | $14k | 0 | Oct 8, 2025 |
| Oct 7, 2025 | CARM Carisma Therapeutics Inc. | MOption exercise Stock Option (right to buy)derivative | -56,982 | $0.00 | $0 | 0 | Oct 8, 2025 |
| Oct 1, 2025 | CARM Carisma Therapeutics Inc. | SOpen-market sale Common Stock | -165,000 | $0.26 | $42k | 319,347 | Oct 3, 2025 |
| Oct 2, 2025 | CARM Carisma Therapeutics Inc. | SOpen-market sale Common Stock | -200,000 | $0.25 | $51k | 119,347 | Oct 3, 2025 |
| Oct 3, 2025 | CARM Carisma Therapeutics Inc. | SOpen-market sale Common Stock | -119,347 | $0.26 | $31k | 0 | Oct 3, 2025 |
| Jan 28, 2025 | CARM Carisma Therapeutics Inc. | AGrant or award Stock Option (Right to Buy)derivative | +221,000 | $0.00 | $0 | 221,000 | Jan 30, 2025 |
Questions about Michael Klichinsky
Answered from the filings on this page, as of the latest one.
Is Michael Klichinsky buying or selling?
Not in the last 12 months. Michael Klichinsky's latest open-market trade on SEC Form 4 was sold $14k of CARM on Oct 7, 2025.
How did Michael Klichinsky's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael Klichinsky has 0.
Where does Michael Klichinsky file Form 4?
Michael Klichinsky has filed Form 4 at CARM (Carisma Therapeutics Inc.) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.